146 related articles for article (PubMed ID: 35516432)
1. Dehydroquinate Synthase Directly Binds to Streptomycin and Regulates Susceptibility of
Wei W; Qiao J; Jiang X; Cai L; Hu X; He J; Chen M; Yang M; Cui T
Front Microbiol; 2022; 13():818881. PubMed ID: 35516432
[TBL] [Abstract][Full Text] [Related]
2. Structure of dehydroquinate synthase reveals an active site capable of multistep catalysis.
Carpenter EP; Hawkins AR; Frost JW; Brown KA
Nature; 1998 Jul; 394(6690):299-302. PubMed ID: 9685163
[TBL] [Abstract][Full Text] [Related]
3. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
[TBL] [Abstract][Full Text] [Related]
4. IMB-T130 targets 3-dehydroquinate synthase and inhibits Mycobacterium tuberculosis.
Zhu N; Wang X; Li D; Lin Y; You X; Jiang J; Xu Y; Jiang W; Si S
Sci Rep; 2018 Nov; 8(1):17439. PubMed ID: 30487577
[TBL] [Abstract][Full Text] [Related]
5. In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis.
Isa MA; Majumdhar RS; Haider S
J Mol Model; 2018 May; 24(6):132. PubMed ID: 29752576
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, crystallization and preliminary X-ray crystallographic analysis of 3-dehydroquinate synthase, Xoo1243, from Xanthomonas oryzae pv. oryzae.
Ngo PT; Natarajan S; Kim H; Hung HK; Kim JG; Lee BM; Ahn YJ; Kang LW
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Dec; 64(Pt 12):1128-31. PubMed ID: 19052366
[TBL] [Abstract][Full Text] [Related]
7. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis.
Mailaender C; Reiling N; Engelhardt H; Bossmann S; Ehlers S; Niederweis M
Microbiology (Reading); 2004 Apr; 150(Pt 4):853-864. PubMed ID: 15073295
[TBL] [Abstract][Full Text] [Related]
8. Biophysical and kinetic analysis of wild-type and site-directed mutants of the isolated and native dehydroquinate synthase domain of the AROM protein.
Park A; Lamb HK; Nichols C; Moore JD; Brown KA; Cooper A; Charles IG; Stammers DK; Hawkins AR
Protein Sci; 2004 Aug; 13(8):2108-19. PubMed ID: 15273308
[TBL] [Abstract][Full Text] [Related]
9. Expression, Purification, and Characterisation of Dehydroquinate Synthase from Pyrococcus furiosus.
Negron L; Patchett ML; Parker EJ
Enzyme Res; 2011; 2011():134893. PubMed ID: 21603259
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ligand-induced conformational changes and domain closure mechanisms, between prokaryotic and eukaryotic dehydroquinate synthases.
Nichols CE; Ren J; Leslie K; Dhaliwal B; Lockyer M; Charles I; Hawkins AR; Stammers DK
J Mol Biol; 2004 Oct; 343(3):533-46. PubMed ID: 15465043
[TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis.
Ruiz P; Rodríguez-Cano F; Zerolo FJ; Casal M
Microb Drug Resist; 2002; 8(2):147-9. PubMed ID: 12118520
[TBL] [Abstract][Full Text] [Related]
13. [Rifampicin-resistant Mycobacterium bovis BCG strain isolated from an infant with NEMO mutation].
Çavuşoğlu C; Edeer Karaca N; Azarsız E; Ulusoy E; Kütükçüler N
Mikrobiyol Bul; 2015 Apr; 49(2):272-7. PubMed ID: 26167828
[TBL] [Abstract][Full Text] [Related]
14. Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance.
Bobadilla-del Valle M; Torres-González P; Cervera-Hernández ME; Martínez-Gamboa A; Crabtree-Ramirez B; Chávez-Mazari B; Ortiz-Conchi N; Rodríguez-Cruz L; Cervantes-Sánchez A; Gudiño-Enríquez T; Cinta-Severo C; Sifuentes-Osornio J; Ponce de León A
PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004124. PubMed ID: 26421930
[TBL] [Abstract][Full Text] [Related]
15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
16. Identification of many crystal forms of Aspergillus nidulans dehydroquinate synthase.
Nichols CE; Ren J; Lamb H; Haldane F; Hawkins AR; Stammers DK
Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):306-9. PubMed ID: 11173489
[TBL] [Abstract][Full Text] [Related]
17. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
[TBL] [Abstract][Full Text] [Related]
18.
Schwarz MGA; Antunes D; Corrêa PR; da Silva-Gonçalves AJ; Malaga W; Caffarena ER; Guilhot C; Mendonça-Lima L
Front Microbiol; 2020; 11():624121. PubMed ID: 33510737
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced conformational changes and a mechanism for domain closure in Aspergillus nidulans dehydroquinate synthase.
Nichols CE; Ren J; Lamb HK; Hawkins AR; Stammers DK
J Mol Biol; 2003 Mar; 327(1):129-44. PubMed ID: 12614613
[TBL] [Abstract][Full Text] [Related]
20. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
